SELLAS Life Sciences Announces Settlement of Counterclaims Against JGB (Cayman) Newton for $6.6 Million Payment by JGB Pharmaceutical Investing
Hemostemix Announces Development of an ACP-01 Allogeneic Process and Initiation of R&D for Autologous NCP-01 Life Science Investing
Novelion Therapeutics Subsidiary Enters Into Term Loan Agreement and Novelion Provides Business Update Pharmaceutical Investing
ASLAN Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update Pharmaceutical Investing
Bellerophon Provides Business Update and Reports Third Quarter 2018 Financial Results Pharmaceutical Investing
